Request Appointment
12902 USF Magnolia DriveTampa, FL 33612
Overview of Dr. Creelan
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2010 - 2013
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2007 - 2010- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2007
Certifications & Licensure
FL State Medical License 2009 - 2028
PA State Medical License 2007 - 2010
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
Clinical Trials
- Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC Start of enrollment: 2023 Mar 10
Roles: Contact
- Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC Start of enrollment: 2025 Jul 17
- DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2023 Jul 26
Publications & Presentations
PubMed
- 1 citationsSIRT2-mediated deacetylation of LCK governs the magnitude of T cell receptor signaling.Imene Hamaidi, Pingyan Cheng, Soo Young Jun, Alak Manna, Min-Hsuan Wang
Nature Immunology. 2026-02-01 - 2 citationsDeveloping SEMA4A-directed CAR T cells to overcome low BCMA antigen density in multiple myeloma.Francesco Di Meo, Francesca Albano, Annamaria Cesarano, Yunfei Wang, Brandon Kale
Cancer Cell. 2025-12-08 - 5 citationsImpaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.Chao Wang, Xiaoqing Yu, Jamie K Teer, Jiqiang Yao, Dongliang Du
Nature Cancer. 2025-05-01
Press Mentions
Tumor Antigen Reactivity Plays Important Role in TIL Therapy EfficacyMay 8th, 2025
Reactivity to Tumor Antigens Is Important for TIL TherapyMay 8th, 2025
Moffitt Researchers Highlight Crucial Role of Tumor Antigen Reactivity in Enhancing TIL TherapyMay 8th, 2025
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
